News Chai raises $130m for AI drug discovery platform AI specialist Chai Discovery has said it is sitting on a valuation of around $1.3 billion, after raising $130 million in a Series B financing.
News Lab-in-a-loop specialist Relation attracts Novartis alliance UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.
News FDA backs first AI tool for use in trials, targeting MASH The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with MASH to help measure disease activity.
News FDA doubles down on its push into AI The FDA has revealed the latest element in its adoption of AI, an agentic AI platform that agency staffers can use to streamline complex tasks.
News Platform tests commercial algorithms for NHS use for bias A platform that can test whether AI algorithms developed for NHS applications are fit for purpose and free of bias has shown its value in a new study.
News NICE backs five AI tools for bowel cancer screening Five AI technologies used during a colonoscopy exam to help detect the early signs of bowel cancer have been backed for use by the NHS in England.
News Genmab ends lung cancer drug development Genmab has decided to stop development of a drug for cancer, acasunlimab for non-small cell lung cancer, following a review of its pipeline.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.